Fluctuating

WASHINGTON – In the competitive arena of mass tort litigation, lawyers and firms vie for leads in cases that range from defective drugs to flawed medical devices. The buying and selling of these leads have become a cornerstone for plaintiff firms specializing in mass tort actions, essentially consumer lawsuits against manufacturers and large corporations. Pricing for these leads not only reflects the demand for specific torts but also serves as a barometer for perceived market value and litigation success potential. Our law firm consistently evaluates the landscape of mass tort leads but opts against purchasing … Read more